5 Lessons Learned on Controlling Fermentation Facility Capital Costs
By Mark Warner, PE, Founder, Warner Advisors LLC Special to The Digest Biotechnology funding is surging and contract fermentation options remain limited, so companies seeking to commercialize advanced biotechnologies are again evaluating options to build required production capacity. While the “build” approach comes with many benefits, capital costs and requisite funding required to build a […]














